Nobuko Nishimura

1.6k total citations
17 papers, 491 citations indexed

About

Nobuko Nishimura is a scholar working on Organic Chemistry, Molecular Biology and Sensory Systems. According to data from OpenAlex, Nobuko Nishimura has authored 17 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Molecular Biology and 5 papers in Sensory Systems. Recurrent topics in Nobuko Nishimura's work include Ion Channels and Receptors (5 papers), Synthetic Organic Chemistry Methods (5 papers) and Asymmetric Synthesis and Catalysis (3 papers). Nobuko Nishimura is often cited by papers focused on Ion Channels and Receptors (5 papers), Synthetic Organic Chemistry Methods (5 papers) and Asymmetric Synthesis and Catalysis (3 papers). Nobuko Nishimura collaborates with scholars based in United States and Japan. Nobuko Nishimura's co-authors include Michael E. Jung, Narender R. Gavva, Rami Tamir, Weiya Wang, Lana Klionsky, Mark H. Norman, David Immke, Yunxin Bo, Michael D. Bartberger and Vijay Gore and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Nobuko Nishimura

17 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuko Nishimura United States 14 224 159 124 66 56 17 491
HyungChul Ryu South Korea 16 280 1.3× 183 1.2× 93 0.8× 24 0.4× 84 1.5× 28 479
Paul A. Glossop United Kingdom 13 221 1.0× 121 0.8× 187 1.5× 70 1.1× 20 0.4× 29 591
Sang-Uk Kang United States 11 85 0.4× 122 0.8× 129 1.0× 38 0.6× 31 0.6× 16 309
Jiawang Zhu United States 8 174 0.8× 96 0.6× 48 0.4× 23 0.3× 24 0.4× 10 320
Hee‐Doo Kim South Korea 12 247 1.1× 63 0.4× 157 1.3× 22 0.3× 28 0.5× 39 434
Nianhe Han United States 11 234 1.0× 54 0.3× 226 1.8× 31 0.5× 16 0.3× 16 442
Graham N. Maw United Kingdom 13 241 1.1× 62 0.4× 215 1.7× 78 1.2× 10 0.2× 28 471
Daniel B. Horne United States 9 427 1.9× 77 0.5× 152 1.2× 19 0.3× 19 0.3× 11 570
John M. Janusz United States 14 268 1.2× 63 0.4× 164 1.3× 37 0.6× 10 0.2× 25 504
Giulia Saponaro Italy 13 181 0.8× 47 0.3× 208 1.7× 104 1.6× 14 0.3× 20 446

Countries citing papers authored by Nobuko Nishimura

Since Specialization
Citations

This map shows the geographic impact of Nobuko Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Nishimura more than expected).

Fields of papers citing papers by Nobuko Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Nishimura. The network helps show where Nobuko Nishimura may publish in the future.

Co-authorship network of co-authors of Nobuko Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Nishimura. A scholar is included among the top collaborators of Nobuko Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Nishimura. Nobuko Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Longbin, Matthew R. Lee, Joseph L. Kim, et al.. (2016). Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorganic & Medicinal Chemistry. 24(10). 2215–2234. 13 indexed citations
2.
Tamayo, Nuria, Mark H. Norman, Michael D. Bartberger, et al.. (2015). Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis. Journal of Medicinal Chemistry. 58(11). 4462–4482. 23 indexed citations
3.
Horne, Daniel B., Nuria Tamayo, Michael D. Bartberger, et al.. (2014). Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists. Journal of Medicinal Chemistry. 57(7). 2989–3004. 36 indexed citations
4.
5.
Wurz, Ryan P., Longbin Liu, Kevin Yang, et al.. (2012). Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. Bioorganic & Medicinal Chemistry Letters. 22(17). 5714–5720. 23 indexed citations
6.
Tamayo, Nuria, Yunxin Bo, Vijay Gore, et al.. (2012). Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists. Journal of Medicinal Chemistry. 55(4). 1593–1611. 46 indexed citations
7.
Norman, Mark H., Jiawang Zhu, Christopher Fotsch, et al.. (2007). Novel Vanilloid Receptor-1 Antagonists:  1. Conformationally Restricted Analogues oftrans-Cinnamides. Journal of Medicinal Chemistry. 50(15). 3497–3514. 35 indexed citations
8.
Klionsky, Lana, Rami Tamir, Weiya Wang, et al.. (2007). Species-Specific Pharmacology of Trichloro(Sulfanyl)ethyl Benzamides as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists. Molecular Pain. 3. 39–39. 90 indexed citations
9.
Wang, Huiling, Balan Chenera, Anthony W. Bannon, et al.. (2007). Novel Vanilloid Receptor-1 Antagonists:  3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties. Journal of Medicinal Chemistry. 50(15). 3528–3539. 44 indexed citations
10.
Jung, Michael E., et al.. (2005). Versatile Diastereoselectivity in Formal [3,3]-Sigmatropic Shifts of Substituted 1-Alkenyl-3-alkylidenecyclobutanols and Their Silyl Ethers. Journal of the American Chemical Society. 127(32). 11206–11207. 18 indexed citations
11.
Jung, Michael E. & Nobuko Nishimura. (2001). Enantioselective Formal Total Synthesis of (−)-Dysidiolide. Organic Letters. 3(13). 2113–2115. 39 indexed citations
12.
Jung, Michael E. & Nobuko Nishimura. (1999). ChemInform Abstract: Stereoselective Formation of Formal Exo Diels—Alder Adducts of Silyloxydienes and Allenecarboxylates.. ChemInform. 30(34). 1 indexed citations
13.
Jung, Michael E. & Nobuko Nishimura. (1999). Stereoselective Formation of Formal Exo Diels−Alder Adducts of Silyloxydienes and Allenecarboxylates. Journal of the American Chemical Society. 121(14). 3529–3530. 31 indexed citations
14.
Nishimura, Nobuko, et al.. (1996). Novel Application of the Intramolecular Prins Reaction: (-)-Anisatin Model Study. Synlett. 1996(12). 1162–1164. 6 indexed citations
15.
Gobetto, Roberto, Kenneth I. Hardcastle, Shariff E. Kabir, et al.. (1995). .mu.-Hydride Geometry and Dynamics in the Protic Acid Adducts of Triosmium Imidoyl Clusters. Organometallics. 14(6). 3068–3080. 16 indexed citations
17.
Shimizu, Norio, et al.. (1987). Cultivation of Escherichia coli harbouring hybrid plasmids. Journal of Fermentation Technology. 65(1). 7–10. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026